middle.news
Alexium Advances R&D Amid 42% Loss Surge: What’s Next for Growth?
6:13pm on Thursday 28th of August, 2025 AEST
•
Chemicals
Read Story
Alexium Advances R&D Amid 42% Loss Surge: What’s Next for Growth?
6:13pm on Thursday 28th of August, 2025 AEST
Key Points
Net loss widened 42.2% to $3.93 million
Revenue declined 33.4% to $3.92 million amid weak US mattress demand
Significant R&D progress in phase change materials and flame retardants
CTO Dr. Robert Brookins to step down, succeeded by Nick Leitner
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Alexium International (ASX:AJX)
OPEN ARTICLE